Skip to content

Text Messaging Reminders for Influenza Vaccine in Primary Care

A Feasibility Study for a Cluster Randomised Trial of Text Messaging Reminders for Influenza Vaccine in Patients Under 65 in Clinical Risk Groups in English Primary Care.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01892631
Acronym
TXT4FLUJAB
Enrollment
156
Registered
2013-07-04
Start date
2013-09-30
Completion date
2015-12-31
Last updated
2016-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Keywords

Text messaging

Brief summary

Influenza morbidity and mortality cause a substantial financial burden to the NHS and to the UK as a whole. Influenza vaccine is safe and effective but is required annually because the circulating strain of virus changes each year. In the UK in 2012, the Chief Medical Officer (CMO) recommended that at least 75% of elderly people (aged 65+) and 75% people under 65 with certain chronic conditions (e.g. chronic heart disease, diabetes, asthma, etc) should be vaccinated. While primary care practices are achieving these targets for elderly patients, those set for younger patients with chronic conditions are not being met, with a third of patients being missed in the 2011/12 flu season and with no substantial improvements in uptake in the past decade. Therefore strategies to increase flu vaccine uptake in these patients are required. Previous trials have shown that patient reminders can increase vaccine uptake and in particular, text messaging has shown to work in some populations in the United States as a cheap, simple and effective reminder. However, whether the same is true in UK general practice is unclear. The use of text messaging in the NHS for appointment reminders is also increasing as it is cheap, quick and effective. Text messaging is already used in roughly 30% of practices to remind patients about their flu vaccine but there has been no trial addressing its effectiveness. Therefore, we propose a trial of a text messaging flu vaccine reminder in patients aged under 65 who have a chronic condition. We hypothesise that practices that send a text message will have increased flu vaccine uptake.

Interventions

OTHERText message influenza vaccination reminder

Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.

OTHERStandard care

Practices in the standard care arm will be asked to proceed with their seasonal influenza campaign as planned.

Sponsors

Wellcome Trust
CollaboratorOTHER
National Health Service, United Kingdom
CollaboratorOTHER_GOV
London School of Hygiene and Tropical Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* practices must use text messaging software to communicate with patients; * practices must not have used a text message to remind patients aged under 65 about influenza vaccine in the 2012/13 influenza season. * practices will send the text message to eligible patients who are aged between 18 and 65, with one of the following risk conditions: chronic respiratory disease, chronic liver disease, chronic kidney disease, chronic heart disease, chronic neurological disease, immunosuppression

Exclusion criteria

* practices will not send the text message to pregnant women.

Design outcomes

Primary

MeasureTime frame
Proportion of patients at risk who received flu vaccineup to 9 months

Secondary

MeasureTime frameDescription
Proportion of practices reporting 'yes' to difficultiesup to 3 monthsProportion of practices reporting 'yes' that they had difficulties in sending the text message to patients
Recruitment rate3 months after initial contactThis is a pilot feasibility study and recruitment of practices to the trial is an outcome.
Practice delivery of text messageOne month after study start (October 1st 2013)Did the practice send the text message to eligible patients and was the content of the message as described in the protocol.
Were outcome data availableup to 9 monthsWere outcome data regarding text message and flu vaccine uptake available.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026